CD4 and neoplasm: Moreover, shift from Th2 and Th17 to Th1 in the form of cytokine and switching of antibody class were associated with complete response (cure).Interestingly, this immune activation or anti-tumor immune response observed after the combined treatment appears to be mainly due to the depletion in T regulatory cells (CD4+CD25+FoxP3+).